Ghent University Academic Bibliography

Your filters: cql: author="Ozakbas, Serkan" or (type any "bookEditor issueEditor" and editor="Ozakbas, Serkan")

Add to list
- Journal Article
- A1
- open access
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Pakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia Joseph Khoury, Tunde Csepany, Barbara Willekens, et al.

(2025) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 96(4). p.361-369
Add to list
- Journal Article
- A2
- open access
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants : real-world evidence from MSBase

Tim Spelman, Sara Eichau, Raed Alroughani, Serkan Ozakbas, Samia J Khoury, Francesco Patti, Eva Kubala Havrdova, Cavit Boz, Murat Terzi, Jens Kuhle, et al.

(2024) MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL TRANSLATIONAL AND CLINICAL. 10(2). p.1-13
Add to list
- Journal Article
- A1
- open access
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

David Levitz, Yi Chao Foong, Paul Sanfilippo, Tim Spelman, Louise Rath, Angie Roldan, Anoushka Lal, Mastura Monif, Vilija Jokubaitis, Serkan Ozakbas, et al.

(2024) THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 17.
Add to list
- Journal Article
- A1
- open access
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Izanne Roos, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Jeannette Lechner-Scott, Suzanne Hodgkinson, Raed Alroughani, Sara Eichau Madueño, Cavit Boz, Anneke van der Walt, et al.

(2024) MULTIPLE SCLEROSIS JOURNAL. 30(9). p.1163-1175
Add to list
- Journal Article
- A1
- open access
Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies

Wei Z. Yeh, Anneke Van Der Walt, Olga G. Skibina, Tomas Kalincik, Raed Alroughani, Allan G. Kermode, Marzena J. Fabis-Pedrini, William M. Carroll, Jeannette Lechner-Scott, Cavit Boz, et al.

(2024) NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 11(6).
Add to list
- Journal Article
- A1
- open access
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Anoushka P. Lal, Yi Chao Foong, Paul G. Sanfilippo, Tim Spelman, Louise Rath, David Levitz, Marzena Fabis-Pedrini, Matteo Foschi, Mario Habek, Tomas Kalincik, et al.

(2024) JOURNAL OF NEUROLOGY. 271. p.5813-5824
Add to list
- Journal Article
- A1
- open access
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis : recruitment challenges, potential bias, and statistical strategies

Ying Li, Alice Saul, Bruce Taylor, Anne-Louise Ponsonby, Steve Simpson-Yap, Leigh Blizzard, Simon Broadley, Jeannette Lechner-Scott, Rana Karabudak, Francesco Patti, et al.

(2024) JOURNAL OF NEUROLOGY. 271. p.472-485
Add to list
- Journal Article
- A1
- open access
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis : a longitudinal analysis of global and national registries

Sifat Sharmin, Izanne Roos, Charles B Malpas, Pietro Iaffaldano, Marta Simone, Massimo Filippi, Eva Kubala Havrdova, Serkan Ozakbas, Vincenzo Brescia Morra, Raed Alroughani, et al.

(2024) LANCET CHILD & ADOLESCENT HEALTH. 8(5). p.348-357
Add to list
- Journal Article
- A2
- open access
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis : results from the MSBase registry

Tim Spelman, Serkan Ozakbas, Raed Alroughani, Murat Terzi, Suzanne Hodgkinson, Guy Laureys (UGent) , Tomas Kalincik, Anneke Van Der Walt, Bassem Yamout, Jeannette Lechner-Scott, et al.

(2023) NEURODEGENERATIVE DISEASE MANAGEMENT. 13(4). p.215-221
Add to list
- Journal Article
- A1
- open access
Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation

Chao Zhu, Tomas Kalincik, Dana Horakova, Zhen Zhou, Katherine Buzzard, Olga Skibina, Raed Alroughani, Guillermo Izquierdo, Sara Eichau, Jens Kuhle, et al.

(2023) JAMA NEUROLOGY. 80(7). p.739-748

Academic Bibliography

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants : real-world evidence from MSBase

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis : recruitment challenges, potential bias, and statistical strategies

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis : a longitudinal analysis of global and national registries

A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis : results from the MSBase registry

Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation

Contents

Support

Contact